"The doctors and researchers who study insulin say it is yet another example — along with EpiPens and decades-old generic drugs — of companies raising the cost of their products because of the lax regulatory environment around drug pricing. “They are doing it because they can,” Jing Luo, a researcher at Brigham and Women’s Hospital, told Vox in 2017, “and it’s scary because it happens in all kinds of different drugs and drug classes.”
This paragraph tells the story. They raise prices because they literally hold peoples’ lives in their hands, and if they can’t or won’t pay the price, they will die, often pretty damned horribly. As “government regulation” became a curse word, of course industry took full advantage. 
